Ottimo Pharma appoints Roger Dansey, M.D. to Board of Directors
10 Apr 2025 //
GLOBENEWSWIRE
Ottimo Pharma boosts leadership with senior Appointments
25 Feb 2025 //
PR NEWSWIRE
Ottimo Pharma Raises over $140 Million in Series A Financing
19 Dec 2024 //
PR NEWSWIRE
Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic
19 Dec 2024 //
FIERCE BIOTECH
Ottimo Pharma Launches with PD1/VEGFR2 Antibody Development
28 Oct 2024 //
PR NEWSWIRE